The GLP-1 receptor agonist market has been gaining popularity over the recent years owing to the growing prevalence of diabetes globally. GLP-1 receptor agonists act by increasing insulin secretion and reducing glucagon secretion in patients with type-2 diabetes. Some key advantages of GLP-1 receptor agonists include their ability to induce significant weight loss in patients and their low risk...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian